Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SECOND SIGHT MEDICAL PRODUCTS, INC.

(EYES)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Certain Warrants of Second Sight Medical Products, Inc. are subject to a Lock-Up Agreement Ending on 23-JUL-2021.

07/23/2021 EDT

Certain Warrants of Second Sight Medical Products, Inc. are subject to a Lock-Up Agreement Ending on 23-JUL-2021. These Warrants will be under lockup for 31 days starting from 22-JUN-2021 to 23-JUL-2021. Details: The company's directors and officers have agreed for a period of 30 days after the date of this prospectus supplement, without the prior written consent of the representative, not to directly or indirectly issue, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of any shares of common stock or other capital stock or any securities convertible into or exercisable or exchangeable for common stock or other capital stock; or file or cause the filing of any registration statement under the Securities Act with respect to any shares of common stock or other capital stock or any securities convertible into or exercisable or exchangeable for common stock or other capital stock; or complete any offering of debt securities of the Company, other than entering into a line of credit, term loan arrangement or other debt instrument with a traditional bank; or enter into any swap or other agreement, arrangement, hedge or transaction that transfers to another, in whole or in part, directly or indirectly, any of the economic consequences of ownership of common stock or other capital stock or any securities convertible into or exercisable or exchangeable for common stock or other capital stock, whether any transaction described in any of the foregoing bullet points is to be settled by delivery of common stock or other capital stock, other securities, in cash or otherwise, or publicly announce an intention to do any of the foregoing.


ę S&P Capital IQ 2021
All news about SECOND SIGHT MEDICAL PRODUCTS, INC.
08/13SECOND SIGHT MEDICAL PRODUCTS : Management's Discussion and Analysis of Financia..
AQ
08/13Second Sight Medical Products, Inc. Reports Earnings Results for the Second Q..
CI
08/11SECOND SIGHT MEDICAL PRODUCTS : Obtains New NIH Grant Supplement for Visual Neur..
MT
08/11SECOND SIGHT MEDICAL PRODUCTS : Announces a New NIH Grant Supplement for Its Ori..
BU
08/04SECOND SIGHT MEDICAL PRODUCTS INC : Other Events (form 8-K)
AQ
08/04Second Sight Medical Products, Inc. Receives Grant from the National Institut..
CI
07/23NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
07/23Certain Common Stock of Second Sight Medical Products, Inc. are subject to a ..
CI
07/23Certain Stock Options of Second Sight Medical Products, Inc. are subject to ..
CI
07/23Certain Warrants of Second Sight Medical Products, Inc. are subject to a Lock..
CI
More news
Financials (USD)
Sales 2020 - - -
Net income 2020 -14,9 M - -
Net cash 2020 0,98 M - -
P/E ratio 2020 -2,59x
Yield 2020 -
Capitalization 127 M 127 M -
EV / Sales 2019 24,8x
EV / Sales 2020 -
Nbr of Employees 11
Free-Float 74,8%
Chart SECOND SIGHT MEDICAL PRODUCTS, INC.
Duration : Period :
Second Sight Medical Products, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SECOND SIGHT MEDICAL PRODUCTS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Managers and Directors
Scott Dunbar Chief Executive Officer
Gregg G. Williams Chairman
Jessy Dorn Vice President-Clinical & Scientific Affairs
Edward Randolph Vice President-Operations
Aaron Mendelsohn Independent Director
Sector and Competitors